Nav: Home

A new tool for forecasting the behavior of the microbiome

June 27, 2016

A team of investigators from Brigham and Women's Hospital and the University of Massachusetts have developed a suite of computer algorithms that can accurately predict the behavior of the microbiome - the vast collection of microbes living on and inside the human body. In a paper published in Genome Biology, the authors show how their algorithms can be applied to develop new treatments for serious diarrheal infections, including Clostridium difficile, and inflammatory bowel disease. The team also shows how to identify bacteria most crucial for a healthy and stable microbial community, which could inform the development of probiotics and other therapies.

The open source software package the researchers have designed, known as Microbial Dynamical Systems INference Engine (MDSINE), uses advanced machine learning technologies to accurately predict how microbial communities in the gut will grow and interact over time. The team validated MDSINE using extensive computational simulations, and also applied the software to infection experiments to evaluate the dynamics of C. difficile, a bacterial species that is the most common cause of infection in the hospital and can cause serious illness and even death in patients. The team also analyzed the effects of a "probiotic cocktail" of various bacterial strains that is being developed to treat inflammatory diseases, predicting the contributions of each member of the cocktail to maintain the stability of the bacterial community when diet was altered.

"Every person has their own bacterial ecosystem living within them. There's a lot of exciting new evidence that giving patients bacteriotherapies, or cocktails of bacteria, may be effective in treating or preventing a variety of major diseases including infections, arthritis, inflammatory bowel disease, and cancer. MDSINE is the first tool we've developed under the new BWH Precision Medicine Initiative, and we're releasing it as open source software in that hope that it will help to advance the bacteriotherapy field," said senior author Georg Gerber, MD, PhD, MPH, Assistant Professor in Computational Pathology at BWH and Co-Director of the Massachusetts Host-Microbiome Center at BWH.

"Advanced computational methods like MDSINE are essential for understanding how to design and evaluate bacteriotherapies or `bugs as drugs,' and to tailor them to individual patients since everyone's microbiome is different. Our results have given us insights into new bacteriotherapies for C. difficile infection and inflammatory bowel disease, and moreover suggest general strategies for developing these therapies for many other diseases," said Vanni Bucci, PhD, first author of the study and an assistant professor at the University of Massachusetts at Dartmouth.
-end-
Paper cited: Bucci V et al. "MDSINE: Microbial Dynamical Systems Inference Engine for Microbiome Time-Series Analyses" Genome Biology DOI: 10.1186/s13059-016-0980-6

Brigham and Women's Hospital

Related Inflammatory Bowel Disease Articles:

Are steroids used too much for patients with inflammatory bowel disease?
Steroid therapy is commonly used to treat acute attacks of the inflammatory bowel diseases ulcerative colitis and Crohn's disease; however, because it does not provide long-term benefits and it carries a risk of serious side effects, it should not be used to treat inflammatory bowel disease for more than three months.
FODMAPs diet relieves symptoms of inflammatory bowel disease
New research from King's College London has found that a diet low in fermented carbohydrates has improved certain gut symptoms and improved health-related quality of life for sufferers of inflammatory bowel disease (IBD).
The diet-microbiome connection in inflammatory bowel disease
A change in diet is a go-to strategy for treating inflammatory bowel diseases like Crohn's.
Edinburgh is global hotspot for inflammatory bowel disease rates
Edinburgh has some of the highest known rates of inflammatory bowel disease in the world and the figure is expected to rise in the next 10 years.
Medication linked to increased risk of inflammatory bowel disease
Medications that target tumor necrosis factor alpha (TNF╬▒), a protein involved in inflammation, have revolutionized the management of certain autoimmune diseases, but paradoxically, these agents might provoke the development of other autoimmune conditions.
More Inflammatory Bowel Disease News and Inflammatory Bowel Disease Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...